Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter's Transformation

被引：20

作者：

Ortiz-Maldonado, Valentin ^{[1
,2
]}

Frigola, Gerard ^{[3
]}

Espanol-Rego, Marta ^{[4
]}

Balague, Olga ^{[2
,3
]}

Martinez-Cibrian, Nuria ^{[1
]}

Magnano, Laura ^{[1
,2
]}

Gine, Eva ^{[1
,2
,5
]}

Pascal, Mariona ^{[4
]}

Correa, Juan G. ^{[1
]}

Martinez-Roca, Alexandra ^{[1
]}

Cid, Joan ^{[2
,6
]}

Lozano, Miquel ^{[2
,6
,7
]}

Villamor, Neus ^{[2
,5
,8
]}

Benitez-Ribas, Daniel ^{[2
,4
]}

Esteve, Jordi ^{[1
,2
,9
]}

Lopez-Guillermo, Armando ^{[1
,2
,5
,7
]}

Campo, Elias ^{[2
,3
,5
,7
,8
]}

Urbano-Ispizua, Alvaro ^{[1
,2
,7
,9
]}

Juan, Manel ^{[2
,4
,7
]}

Delgado, Julio ^{[1
,2
,5
,7
]}

机构：

[1] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain

[2] Inst dInvest Biomed August Pi Sunyer IDIBAPS, Oncol & Hematol, Barcelona, Spain

[3] Hosp Clin Barcelona, Dept Pathol, Barcelona, Spain

[4] Hosp Clin Barcelona, Dept Immunol, Barcelona, Spain

[5] Ctr Invest Biomed Red Canc CIBERONIC, Barcelona, Spain

[6] Hosp Clin Barcelona, Dept Hemotherapy & Hemostasis, Apheresis & Cell Therapy Unit, Barcelona, Spain

[7] Univ Barcelona, Dept Med, Barcelona, Spain

[8] Hosp Clin Barcelona, Hematopathol Unit, Barcelona, Spain

[9] Inst Res Josep Carreras, Stem Cell Transplant & Cell Immunotherapy Grp, Barcelona, Spain

来源：

FRONTIERS IN ONCOLOGY | 2022年 / 12卷

关键词：

CLL; CART; CD19; DLBCL; Richter disease; CHIMERIC ANTIGEN RECEPTOR; RECOMMENDATIONS;

D O I：

10.3389/fonc.2022.828471

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CART19 cells are emerging as an alternative therapy for patients with chronic lymphocytic leukemia (CLL). Here we report the outcome of nine consecutive patients with CLL treated with ARI-0001 CART19 cells, six of them with Richter's transformation (RT). One patient with RT never received therapy. The cytokine release syndrome rate was 87.5% (12.5% grade >= 3). Neurotoxicity was not observed in any patient. All patients experienced absolute B-cell aplasia, and seven (87.5%) responded to therapy. With a median follow-up of 5.6 months, two patients with RT experienced a CD19-negative relapse. In conclusion, ARI-0001 cell therapy was feasible, safe, and effective in patients with high-risk CLL or RT.

引用

页数：7

共 50 条

[41] Hepatic Superscan on PET/CT Due to Richter's Transformation of Chronic Lymphocytic Leukemia
Taneja, Sanjeev
Achong, Dwight M.
CLINICAL NUCLEAR MEDICINE, 2010, 35 (08) : 644 - 645
[42] Multiple cell cycle regulator alterations in Richter's transformation of chronic lymphocytic leukemia
F Cobo
A Martínez
M Pinyol
L Hernández
M Gómez
S Beá
J Esteve
M Rozman
F Bosch
A López-Guillermo
E Montserrat
E Campo
Leukemia, 2002, 16 : 1028 - 1034
[43] Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib
Hampel, Paul J.
Cherng, Hua-Jay J.
Call, Timothy G.
Ding, Wei
Khanlari, Mahsa
McPhail, Ellen D.
Miranda, Roberto N.
Lin, Pei
Tawbi, Hussein A.
Ferrajoli, Alessandra
Wierda, William G.
Jain, Nitin
Parikh, Sameer A.
BLOOD ADVANCES, 2020, 4 (18) : 4508 - 4511
[44] Richter's Transformation; the Cause of Fever of Unknown Origin in a Case with Chronic Lymphocytic Leukemia
Kurtaran, Behice
Paydas, Semra
Yavuz, Sinan
Candevir, Ashhan
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2009, 19 (03): : 180 - 183
[45] AKT activation in Chronic Lymphocytic Leukemia cells promotes transformation towards aggressive Richter's syndrome lymphoma
Nickel, N.
Al-Maarri, M.
Pal, M.
Roth, A.
Schaefer, S.
Buettner, R.
Hallek, M.
Wunderlich, T.
Pallasch, C. P.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 13 - 13
[46] AKT ACTIVATION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS PROMOTES TRANSFORMATION TOWARDS AGGRESSIVE RICHTER'S SYNDROME LYMPHOMA
Al-Maarri, M.
Nickel, N.
Roth, A.
Hoevelmeyer, N.
Hallek, M.
Wunderlich, F. T.
Pallasch, C.
HAEMATOLOGICA, 2016, 101 : 10 - 10
[47] RICHTER'S TRANSFORMATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): ANALYSIS OF BIOLOGICAL AND CLINICAL RISK FACTORS AND OUTCOMES
Gershom, E.
Huang, S.
Ye, M. Suhua
Ahmed, M.
Gillan, T. L.
Gerrie, A. S.
Leitch, H. A.
Toze, C. L.
Ramadan, K. M.
HAEMATOLOGICA, 2014, 99 : 59 - 59
[48] A Systematic Review on the Prevention and Control of Opportunistic Infections in Patients With Chronic Lymphocytic Leukemia Complicated by Richter's Transformation
Arzoun, Hadia
Srinivasan, Mirra
Sandoval, Stephanie
Lee, Bridget
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
[49] Richter's Transformation after CD-19 Directed CAR-T Cells for Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Blackmon, Amanda
Danilov, Alexey V.
Wang, Lili
Pillai, Raju
Mirshkarlo, Hormoz Babaei
Rosen, Steven T.
Siddiqi, Tanya
BLOOD, 2021, 138
[50] Richter's transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study
Ben-Dali, Yasmin
Hleuhel, Mariam H.
da Cunha-Bang, Caspar
Brieghel, Christian
Poulsen, Christian B.
Clasen-Linde, Erik
Bentzen, Hans H. N.
Frederiksen, Henrik
Christiansen, Ilse
Nielsen, Linda H.
Enggaard, Lisbeth
Helleberg, Marie
Clausen, Michael
Frederiksen, Mikael
Pedersen, Robert S.
Niemann, Carsten U.
Andersen, Michael A.
LEUKEMIA & LYMPHOMA, 2020, 61 (06) : 1435 - 1444

← 1 2 3 4 5 →